Connect with us

Cannabis News

California Senate Passes Bill To Delay Marijuana Tax Hike That Already Cleared Assembly In Earlier Form

Published

on

The California Senate has accepted an invoice for the assembly Place the tax hike about this new pause in marijuana products.

The Senate’s pouring committee cleaned the Commission for a week after Matt Haney (d) cleaned the legislation from the Assembly, the whole chamber passed on Wednesday.

Because it was changed, the measure must return to the meeting before sending the governor’s table.

If it is suspended in law, the invoice would interrupt the tax rise for five years. Legislators have until September 12 before the end of the session, and the governor will take measures to its table until October 12.

Christopher Cabaldon (D) said the voting of the Senate that the legalization of the California voters had several goals, including “extinguishing the ilient market” and “environmental social and educational programs” with income income.

“This deal is fraying, because the market collapses,” he said. “Today, California’s legal businesses catch up to 40 percent of the cannabis market. There are six seventy of illegal market, consumer or non-environmental protection.”

“California is losing other states,” Cabaldon said. “Michigan, Oregon and others have much more income and many better work is being done to stop illegal sales. And so there is no tax to rise to 25 percent.”

Jerry McNerney (d) Husbands added “We want to control and reduce the illegal market”.

“The growth of taxes will be the opposite effect,” he said. “People will lead to the illegal black market in cannabis, it’s a bad result.”

A correction taken in the stops of the Senate panel, so the effective date would be in October than immediately. The tax hike ride herself in the last month.

In June, the tax rate of the cannabis rose by 15 percent from July 1, and the advocates would change the budget legislation that would reflect the standalone bill in Hanyy. That was not fruit.

Haney’s measurements passage the budget bill gov. The Gavin Newsom (d) support had a tax freezing tax on the trailer. Assembly speaker Robert Rivas (D) also protected the delay, but Mike McGuire (d) Senate President has blocked From the budget legislation.

Under the Bill of Haney, What advanced through the assembly in JuneThe delayed implementation would not be in force until October. The advocates wanted to see recently, they wanted to see what has been included in the legislation in the legislation, which would affect it.

Before you submission to the Senate Endowing Tax, so until two years, the regulators would adapt the tax rate “, in accordance with non-uninterestaneous tools, it is not exceeded by 19 per cent,” according to a summary. “

The appropriate committee, however, would be to summarize the period of 15% of the tax rate and request the report, “according to the chair. It is not clear what the new timeline would be, however, the revised bill text is not yet available.

Haney’s proposal therefore, therefore, the California tax rate (CDTFA), can adjust the cannabis or cannabis tax rate “, the amount of income that will generate the amount of income by departmental estimators. Fiscal year” text He says.

The department should calculate the amount of income that would meet in the previous year in the previous year “and” calculate this amount by projecting tools based on the work that would meet in the previous calendar work in the previous year.

“The exact goal of the reduction in the tax rate of Kannabis is to provide immediate tax relief to the cannabis industry,” said the measurements. “The effectiveness of this goal can be measured according to the legislature, for the income income of cannabis tax revenue, allowed to reduce the tax rate of cannabis.”

CDTFA, on December 1, 2026, also promises California “Send to the Report to Legislature … CANNABISA Tax revenue income income amounts or loss amounts to reduce the tax rate permitted by this action.”


Marijuana is a moment Monitoring of hundreds of cannabis, psychedelic and drug policy invoices This year’s state legislatures and congresses. Patreon supporters At least $ 25 / monthly enter our interactive maps, graphs and listening to the listening calendar, so they do not lose development.


Learn more about us Marihuana Bill Tracker and become Assistant Patreon to get access.

The Senate’s Endowing Committee last week, also passed by unanimously legislation Kalamu-derived cannabinoid products to integrate the use of medical and adults in the marijuana program to ban cannabinoids derived synthetically. The tables “to delete tax provisions, reviewing and modifying specifications, to review and change the conditions and prohibitions on cannabinoids derived from hemp and hemp,” according to the Chair of the Commission.

He accepted the panel measure To change the law of State Cannabis, cannabis microbusinesses, licensing products directly to patients directly with corrections.

Meanwhile, California officials invite research proposals in the second round of a program Better educate the public on the state marijuana law And politicians help make informed decisions on the subject.

In June, the Governor’s Business and Economic Development Office (Go-Biz) An announced receivers of more than $ 52 million in Community reinvestment support He also financed the non-profit and local health department, Marijuana tax tickets.

This marked Cannabis’s seventh round of Construction Community Conversation (CalCRG) Under the state program.

Legitiation in California has created a number of new grant programs to address the consequences of marijuana prohibition and try to feed the strong and well regulated legal industry.

The Supreme Court of California distinguished the victory for the state marijuana program In June, recovering a smaller quantity judgment, in a case, in a case, he suggested the federal ban, could be used locally to weaken the cannabis market.

The Court of the Supreme Court also arrived in California officials a State Marijuana’s current status and future report-En independent analysts contracted by regulators concluded the Federal Prohibition of Canavies, a federal ban that prevents global trade.

The governor signed an invoice in 2022 Invented to enter the commercial agreements of power of power With other legal states, but this power was on a federal orientation or such an activity was in the evaluation of the State lawyer.

Meanwhile, the California Senate Committee was recently advancing a Bipartisan invoice Psilocybin created a pilot program to military veterans and first answers first.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Become patreon guard!

(Tagstotranslate) highlighted

Continue Reading

Cannabis News

Opening the doors to standardized cannabis propagation

Published

on

By

Twenty cannabis growers from all over Europe and the world recently gathered in Austria for another industry event: a one-day invitation-only masterclass on cannabis propagation, hosted by Fluence, one of Europe’s largest cannabis clone producers, at the Flowery Field in Vienna.

The day included lectures, live demonstrations and a rare guided tour through a facility that is usually closed to outsiders. “It was a good mix of practice and theory,” says Fluence’s Theo Tekstra. “In the morning we had a theoretical block, then we had an in-depth tour of the tissue culture laboratory and the mother plant and reproduction areas, and in the afternoon a practical workshop. Everyone saw and participated in the whole process.”

© Fluence BioengineeringA cannabis tissue culture clone in the early rooting hardening phase was demonstrated at the Flowery Field hands-on session, demonstrating propagation techniques with Fluence LED lighting.

Historical installation
Flowery Field was founded by Alexander Klima, a former law student who noticed that Austrian regulations discriminated between plants and their uses. In practice, this means that cannabis can be sold as an ornamental plant, as long as it is not harvested for consumption.

What started as a small shop selling houseplants along with cannabis cuttings, has since become a major production site, with a hundreds of square meters of mother plant and tissue culture laboratory where eight technicians work every day. The company now focuses entirely on cannabis clones, supplying customers in Austria and neighboring countries, often with same-day delivery to selected locations.

Standardized expansion
For Franz Joseph Sima, Fluence’s long-time propagation specialist, the masterclass aimed to show how standard procedures transform the mother and clone phases of cannabis production. “Many producers still have challenges in the expansion phase,” he said. “At Flory Field, these processes have been refined over twenty years. We wanted participants to see how a consistent and commercially viable system works in practice.”

The workshop covered everything from mother plant maintenance and replacement schedules, to light intensity, watering and pest management. The attendees received the full procedure afterwards. “The only condition,” says Franz, “was to be there.”

© Fluence BioengineeringFranz Josef Sima, Cannabis Research & Plant Specialist at Fluence, guiding participants through best practices in mother plant maintenance and clone cutting.

From tissue culture to mother plant
Participants followed the entire production chain, from tissue culture and virus testing in the laboratory, to cutting and preparation of clones. Flowery uses PCR testing to ensure cultivar stability and purity, a practice more common in pharmaceutical or ornamental horticulture than cannabis.

“The contrast was striking,” says Theo. “You have this sterile white lab on one side, and on the other a fully commercial clone factory based on the mother plants. Seeing both under one roof gave people a real sense of scale.”

Opening the doors
One of the main takeaways from the day was the atmosphere of openness. “In the Dutch horticulture industry, growers thrived by visiting each other and sharing knowledge,” says Theo. “In cannabis, everyone tends to close their doors. Events like this are a step to change that.”

The small group format helped. What began as quiet observation soon turned into a back-and-forth of ideas, with growers comparing notes, solving problems, and sharing their methods.

© Fluence BioengineeringAttendees of the Fluence Propagation Masterclass at Flowery Field in Vienna, a meeting of cannabis cultivation professionals from all over Europe.

Interest in the event exceeded expectations, Franz and Theo both say, and Fluence is already considering repeating the format. “We can do another show in the same place, and maybe even one in the US. It’s something that people can clearly see. In cannabis, very few cloning procedures have been proven for a decade or more, so showing something that has stood the test of time makes a big difference.”

For one day, Flowery Field opened its doors, its laboratories and its mother rooms to a small but focused group of professionals. “In a sector where practical knowledge tends to be kept close to the box, that alone was worth a visit,” concludes Theo.

If you are interested in participating in Fluence Masterclass events across Europe, please get in touch (email protected)

For more information:
fluency
https://fluence-led.com/

Continue Reading

Cannabis News

Oregon Officials Seek To Dismiss Psilocybin Access Lawsuit From Homebound Patients

Published

on

By

“Delays in enabling access mean that patients who achieved relief from debilitating anxiety and depression will die in unrelieved suffering.”

Author: Jack Gorsline, Filter

A The legal battle between the state of Oregon and a group of psilocybin boosters has intensified after the state asked for a second time to throw out their lawsuit.

The group originally sued the Oregon Health Authority in 2024 to prevent disabled and dying Oregonians from accessing psilocybin under the state’s Psilocybin Services Act. At the heart of their complaint is that by limiting services to licensed centers and excluding those who cannot travel, the state is violating the Americans with Disabilities Act (ADA).

The plaintiffs, a group of specialty psilocybin suppliers, filed their brief in a federal District Court in Oregon on October 10, challenging the state’s second attempt to dismiss the case.

The Oregon Health Authority (OHA) filed a motion for judgment on the allegations that the plaintiffs lacked standing to state a claim under the ADA. terminally ill and disabled customers.

That motion was followed by a similar motion filed by OHA and a motion to dismiss the case on similar grounds. it was denied in June

Attorneys for the plaintiffs argue that the OHA is trying to avoid reviewing the merits of the case, thereby perpetuating the illegal exclusion of a vulnerable population.

“Plaintiffs’ promoters have complained enough on their behalf and on behalf of their disabled and dying clients,” said Kathryn Tucker of the National Psychedelic Association, one of the attorneys representing them.

He said the state’s position attempts to sidestep the ADA compliance requirement in the operation of the Psilocybin Services Act.

“OHA seeks to avoid compliance with the ADA in the operation of the PSA, as it unlawfully discriminates against Oregonians,” Tucker said. The filter. “Delays in enabling access mean that patients who achieved relief from debilitating anxiety and depression will die in unrelieved suffering.”

The Psilocybin Services Act, passed by Oregon voters in 2020 to establish a legal and regulatory framework to oversee the use of psilocybin, includes legislative findings and detailed statements of goals that indicate the intent to serve populations such as the terminally ill. The plaintiffs in the lawsuit say that the existing rules, which mandate only service at authorized centers, directly contradict that goal.

The plaintiffs are seeking a court order to require OHA to develop a process for domestic service as a reasonable accommodation, and to notify all licensed facilitators that such accommodations are permitted without fear of disciplinary action.

The ongoing litigation highlights the tension between the state’s innovative regulatory framework and the federal Americans with Disabilities Act, which requires public entities to provide reasonable accommodations to ensure services are accessible to people with disabilities. A previous ruling denying OHA’s motion to dismiss suggested that requiring compliance with the ADA—such as access accommodations—would not necessarily compel the state to violate federal law against the distribution of a Schedule I controlled substance.

However, OHA says that current state law, as written, does not provide a legal means to consume psilocybin outside of a licensed service center, and that accommodating home use would violate the statute. This attitude leaves facilitators who want to serve domestic clients in a precarious situation, at risk of losing their licenses or worse if they provide services outside of regulated centers.

Oregon Health Authority officials did not immediately respond The filterrequests for comments.

Meanwhile, the Psilocybin Services Act was intended to help prevent access to a key population in Oregon. The plaintiffs say the delay in providing accessible services has had far-reaching consequences, especially for terminally ill patients who have limited time to potentially transform the rest of their lives.

If the federal court once again denies OHA’s motion to dismiss the case, it will move closer to deciding whether the state must make accommodations for those clients to perform psilocybin services at home. The result could significantly expand access to the state’s pioneering psilocybin program. It may also affect how other states design their programs.

“We hope the Court will decline to avoid merits review, move the case forward, and ensure access to disabled and dying Oregonians, who are among those most likely to benefit from psilocybin services,” Tucker concluded.

This the article Originally published by the author The filteran online magazine that deals with drug use, drug policy and human rights from a harm reduction perspective. Keep the filter on Bluesky, X or Facebookand sign up for their newsletter.

user photo Wikimedia/Staff.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Local startup expands to 32,000-square-foot cannabis processing facility

Published

on

By











Founded in 2018 by six Greek graduates as a CBD company, NOWAVE’s products can be found in 90 percent of New York state’s legal cannabis dispensaries.

“We started with a 300-square-foot space behind a retail store — actually a vape shop,” recalls founder Brian Lane. “((We) started perfecting our gummies, sending them out to vape shops all over the country. The next thing you know, we found ourselves making quite a few gummies. We were self-taught in all of our product types, and now we’ve grown from that 300 square foot space to where we are right now.”

Approximately 100 people work at the Chili facility, producing hemp and CBD products and processing cannabis into edibles, vaping products, and even carbonated beverages containing THC, the psychoactive ingredient in marijuana.

NOWAVE manufactures products for brands including Off Hours, Eaton Botanicals and Weed Water. The company also makes some of the only vegan gummies on the market.

Read more at 13 Yes










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media